ARTICLE | Clinical News
Milciclib: Ph IIa start
April 27, 2017 9:08 PM UTC
Tiziana will begin in May an open-label, international Phase IIa trial to evaluate 100 mg oral milciclib in about 30 patients who failed to respond to or are intolerant of standard of care (SOC). Pati...